[go: up one dir, main page]

HUP0000168A2 - Eljárás benzoxazinonok aszimetrikus szintézisére - Google Patents

Eljárás benzoxazinonok aszimetrikus szintézisére

Info

Publication number
HUP0000168A2
HUP0000168A2 HU0000168A HUP0000168A HUP0000168A2 HU P0000168 A2 HUP0000168 A2 HU P0000168A2 HU 0000168 A HU0000168 A HU 0000168A HU P0000168 A HUP0000168 A HU P0000168A HU P0000168 A2 HUP0000168 A2 HU P0000168A2
Authority
HU
Hungary
Prior art keywords
alkyl
give
asymmetric synthesis
agent
alkylthio
Prior art date
Application number
HU0000168A
Other languages
English (en)
Inventor
Anusuya Choudhury
Rodney Lawrence Parsons
Michael Ernest Pierce
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of HUP0000168A2 publication Critical patent/HUP0000168A2/hu
Publication of HUP0000168A3 publication Critical patent/HUP0000168A3/hu
Publication of HU225655B1 publication Critical patent/HU225655B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány tárgya új módszer az (S)-6-klór-4-ciklőprőpil-etinil-4-triflűőrmetil-1,4-dihidrő-2H-3,1-benzőxazin-2-őn (VI.i) képletűvegyület aszimmetrikűs szintézisére, amely vegyület hűmán imműnhiányősvírűs (HIV) főrdítőtt transzkriptáz inhibitőr. ŕ
HU0000168A 1996-12-16 1997-12-15 Process for asymmetric synthesis of benzoxazinones HU225655B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3298096P 1996-12-16 1996-12-16
US08/838,838 US5932726A (en) 1996-12-16 1997-04-11 Asymmetric synthesis of benzoxazinones
PCT/US1997/022674 WO1998027073A1 (en) 1996-12-16 1997-12-15 Asymmetric synthesis of benzoxazinones

Publications (3)

Publication Number Publication Date
HUP0000168A2 true HUP0000168A2 (hu) 2000-09-28
HUP0000168A3 HUP0000168A3 (en) 2001-02-28
HU225655B1 HU225655B1 (en) 2007-05-29

Family

ID=26709131

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000168A HU225655B1 (en) 1996-12-16 1997-12-15 Process for asymmetric synthesis of benzoxazinones

Country Status (27)

Country Link
US (1) US5932726A (hu)
EP (1) EP0944610B1 (hu)
JP (1) JP4232911B2 (hu)
KR (1) KR100498665B1 (hu)
CN (1) CN1075063C (hu)
AT (1) ATE289296T1 (hu)
AU (1) AU750047B2 (hu)
BR (1) BR9714031A (hu)
CA (1) CA2275323C (hu)
CZ (1) CZ297168B6 (hu)
DE (1) DE69732525T2 (hu)
EA (1) EA002987B1 (hu)
EE (1) EE03920B1 (hu)
ES (1) ES2235265T3 (hu)
HR (1) HRP970688A2 (hu)
HU (1) HU225655B1 (hu)
IL (2) IL130684A (hu)
LV (1) LV12432B (hu)
NO (1) NO313236B1 (hu)
NZ (1) NZ336163A (hu)
PL (1) PL192661B1 (hu)
PT (1) PT944610E (hu)
RO (1) RO120844B1 (hu)
SI (1) SI20071A (hu)
SK (1) SK285258B6 (hu)
UA (1) UA66773C2 (hu)
WO (1) WO1998027073A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874430A (en) 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
TWI326283B (en) * 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
AU2003248217A1 (en) * 2003-04-04 2004-10-25 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
WO2010032259A2 (en) 2008-05-30 2010-03-25 Emcure Pharmaceuticals Limited Novel process
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
CN101844990B (zh) * 2010-05-27 2013-03-20 浙江沙星医药化工有限公司 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2441759A1 (en) 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
CN102584801B (zh) * 2011-01-06 2015-02-18 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺
WO2015118515A1 (en) * 2014-02-10 2015-08-13 Discovery Intermediates Private Limited An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor
EP2944631A1 (en) * 2014-05-12 2015-11-18 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of Efavirenz
CN104016936B (zh) * 2014-06-18 2016-08-17 中国科学院上海有机化学研究所 手性氨基酚配体在依法韦仑不对称合成中的应用
CN105801442A (zh) * 2015-10-16 2016-07-27 浙江沙星医药化工有限公司 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法
JP6268564B2 (ja) * 2015-12-08 2018-01-31 Dic株式会社 オキサジン化合物、組成物及び硬化物
JP6350889B2 (ja) * 2015-12-08 2018-07-04 Dic株式会社 オキサジン化合物、組成物及び硬化物
CN108368216B (zh) * 2015-12-08 2020-09-18 Dic株式会社 恶嗪化合物、组合物及固化物
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE343057C (de) * 1914-06-21 1921-10-25 Kalle & Co Aktien Ges Verfahren zur Darstellung von 1-Arylamino-4-oxynaphthalinen
US3280120A (en) * 1964-03-09 1966-10-18 Rexall Drug Chemical Substituted benzoxazines, process therefor and intermediates
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3513166A (en) * 1967-05-22 1970-05-19 Robins Co Inc A H 3-(omega-aminoalkyl)-4-substituted-1,3-benzoxazine-2-ones
AU5960380A (en) * 1979-08-30 1981-03-05 A. Ehrenreich G.m.b.H. & Co. KG Bellows seal and retaining ring
DE3622262A1 (de) * 1986-07-02 1988-01-07 Bayer Ag Chromogene 3,1-benzoxazine
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

Also Published As

Publication number Publication date
WO1998027073A8 (en) 1999-11-04
US5932726A (en) 1999-08-03
ATE289296T1 (de) 2005-03-15
LV12432B (en) 2000-07-20
WO1998027073A1 (en) 1998-06-25
SK80399A3 (en) 2000-03-13
NO992914D0 (no) 1999-06-15
EE9900243A (et) 1999-12-15
DE69732525T2 (de) 2006-01-12
HUP0000168A3 (en) 2001-02-28
SI20071A (sl) 2000-04-30
KR100498665B1 (ko) 2005-07-01
IL130684A0 (en) 2000-06-01
LV12432A (lv) 2000-02-20
EP0944610A1 (en) 1999-09-29
NO992914L (no) 1999-06-15
AU5694498A (en) 1998-07-15
CA2275323C (en) 2003-04-08
CN1245493A (zh) 2000-02-23
CA2275323A1 (en) 1998-06-25
EE03920B1 (et) 2002-12-16
EA199900552A1 (ru) 2000-02-28
EA002987B1 (ru) 2002-12-26
SK285258B6 (sk) 2006-10-05
AU750047B2 (en) 2002-07-11
BR9714031A (pt) 2000-05-09
NZ336163A (en) 2001-04-27
HRP970688A2 (en) 1998-10-31
UA66773C2 (uk) 2004-06-15
PL192661B1 (pl) 2006-11-30
PL334281A1 (en) 2000-02-14
PT944610E (pt) 2005-04-29
NO313236B1 (no) 2002-09-02
EP0944610B1 (en) 2005-02-16
JP4232911B2 (ja) 2009-03-04
CN1075063C (zh) 2001-11-21
KR20000057574A (ko) 2000-09-25
HU225655B1 (en) 2007-05-29
JP2001507684A (ja) 2001-06-12
CZ297168B6 (cs) 2006-09-13
IL130684A (en) 2003-12-10
RO120844B1 (ro) 2006-08-30
DE69732525D1 (de) 2005-03-24
ES2235265T3 (es) 2005-07-01
CZ212899A3 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
IL130684A (en) Asymmetric synthesis of benzoxazinones
ATE228151T1 (de) Synergistische flammschutzmittel-kombination für kunststoffe
TW356415B (en) 2-Amino-1,3,5-triazines, processes for their preparation, and their use as herbicides
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
ES8401030A1 (es) Un procedimiento para la preparacion de indol sulfonilureas.
MX9606175A (es) Aminas terciarias y procedimiento para su elaboracion.
ATE133939T1 (de) Indan-1,3-dion und indan-1,2,3-trionderivate, verfahren zu ihrer herstellung und ihrer therapeutische verwendung
GB8628694D0 (en) Anthihypertensive combination product
DE50004141D1 (de) Organosiliciumverbindung, Verfahren zu ihrer Herstellung und deren Verwendung
ATE131167T1 (de) Verfahren zur herstellung von ergolinderivaten.
ATE1904T1 (de) 2-sulfonyl-chinoxaline, verfahren zu ihrer herstellung sowie ihre verwendung als mikrobizide.
EP1178031A4 (en) PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS USING CATALYSTS BASED ON MANGANESE OR THE LIKE
TW372955B (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE59712053D1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PE119599A1 (es) Tetrahidronaftalenos sustituidos y compuestos analogos
NZ334367A (en) Compositions comprising a carbanate and a valine amide for controlling harmful fungi
DE3884319D1 (de) Imidazobenzodiazepine und ihre Säureadditionssalze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen.
HU9401512D0 (en) 2-amino-pyrazine-5-carboxamide derivatives process for producing them and their therapeutic application
DE59712054D1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
MX9801955A (es) Mezclas herbicidas con accion sinergetica.
DE69905761D1 (de) Verfahren zur herstellung vom (r)-(+)-3- 1-[2-(4-benzoyl-2-(3,4-difluorophenyl)morpholin-2-yl)ethyl]-4-phenylpiperidin-4-yl -1,1-dimethylharnstoff, deren salzen, solvaten und/oder hydraten
PT76224B (en) Process for the preparation of a fungicidal composition containing new oximinoacetanilides
ATE89551T1 (de) Verfahren zur herstellung von optisch aktiven acyloxyazetidinonen.
MX9703235A (es) Fenil alquil cetona substituida por amina ciclica y un procedimiento para su preparacion.